摘要:
A rotating electric machine includes a stator core of a cylindrical shape, a rotor core coaxially rotating inside the stator core, and a plurality of coils each formed by winding magnet wires using a slot formed axially in either the stator core or the rotor core, or both: it is preferable that each of the coils be split into a plurality of coil groups, that starting sections of winding of the magnet wires in one of the coil groups be wound adjacently to ending sections of winding of the magnet wires in another of the coil groups, and that the starting sections and ending sections of winding of the magnet wires in the two coil groups be connected at respective outgoing wire ends to one another, outside the slots.
摘要:
A rotating electric machine includes a stator core of a cylindrical shape, a rotor core coaxially rotating inside the stator core, and a plurality of coils each formed by winding magnet wires using a slot formed axially in either the stator core or the rotor core, or both: it is preferable that each of the coils be split into a plurality of coil groups, that starting sections of winding of the magnet wires in one of the coil groups be wound adjacently to ending sections of winding of the magnet wires in another of the coil groups, and that the starting sections and ending sections of winding of the magnet wires in the two coil groups be connected at respective outgoing wire ends to one another, outside the slots.
摘要:
A cyclic amide derivative of formula (I): ##STR1## wherein R.sup.1 represents a substituted alkyl group, a substituted alkenyl group, a substituted amino group, a substituted alkoxyl group, a substituted alkylthio group, a substituted carbamoyl group, a substituted sulfonamide group or a substituted amide group; the ring A represents a saturated cyclic alkyl group with 5 to 7 carbon atoms or a hetero-atom-containing saturated heterocyclic group with 3 to 6 carbon atoms; R.sup.2 represents a hydrogen atom, a substituted or unsubstituted alkyl group, a substituted or unsubstituted aromatic hydrocarbon group or a substituted or unsubstituted heterocyclic group; R.sup.3 represents a hydrogen atom, a group represented by the general formula R.sup.4 O-- or a group represented by the general formula R.sup.5 (R.sup.6)N-- wherein R.sup.4 represents hydrogen atom, a substituted or unsubstituted alkyl group, a substituted or unsubstituted aromatic hydrocarbon group or a substituted or unsubstituted heterocyclic group; R.sup.5 and R.sup.6 may be the same or different and each represents a hydrogen atom, a substituted or unsubstituted alkyl group, a substituted or unsubstituted aromatic hydrocarbon group or a substituted or unsubstituted heterocyclic group.The cyclic amide derivative of formula (I) have a strong and selective inhibitory action of a cathepsin K and a clinical efficacy when administered orally.
摘要翻译:式(I)的环状酰胺衍生物:其中R1表示取代的烷基,取代的烯基,取代的氨基,取代的烷氧基,取代的烷硫基,取代的氨基甲酰基,取代的磺酰胺基或取代的 酰胺基; 环A表示碳原子数5〜7的饱和环状烷基或碳原子数3〜6的含杂原子的饱和杂环基; R 2表示氢原子,取代或未取代的烷基,取代或未取代的芳香族烃基或取代或未取代的杂环基; R3表示氢原子,由通式R4O表示的基团或由通式R5(R6)表示的基团N-,其中R4表示氢原子,取代或未取代的烷基,取代或未取代的芳族烃基或 取代或未取代的杂环基; R 5和R 6可以相同或不同,各自表示氢原子,取代或未取代的烷基,取代或未取代的芳香族烃基或取代或未取代的杂环基。 式(I)的环状酰胺衍生物在口服给药时具有组织蛋白酶K的强烈和选择性抑制作用和临床疗效。
摘要:
A method for detecting a genetic polymorphism(s), comprising creating oligonucleotide probes and/or oligonucleotide primers so that the probes and/or primers contain a polymorphic site(s) present in a gene encoding a receptor or a sequence complementary thereto or so that the polymorphic site(s) is/are contained in the amplified fragment when at least one of said gene encoding the receptor and said sequence complementary thereto is amplified; and detecting at least one genetic polymorphism in a gene of a subject encoding the receptor using the resultant oligonucleotide probes and/or oligonucleotide primers.
摘要:
A method for detecting a genetic polymorphism(s) in a gene encoding cytochrome P450 using as oligonucleotide probes and/or oligonucleotide primers at least one sequence selected from the group consisting of an at least 13 nucleotide sequence within any of the nucleotide sequences as shown in SEQ ID NOS: 1 through 215, said at least 13 nucleotide sequence containing the 21st nucleotide, or a sequence complementary to said at least 13 nucleotide sequence.
摘要翻译:用于使用寡核苷酸探针和/或寡核苷酸引物检测编码细胞色素P450的基因中的遗传多态性的方法,所述寡核苷酸探针和/或寡核苷酸引物至少一个选自下列任一核苷酸序列中的至少13个核苷酸序列的序列,如 SEQ ID NO:1至215,所述至少13个核苷酸序列含有第21个核苷酸,或与所述至少13个核苷酸序列互补的序列。
摘要:
The present invention relates to genetic polymorphism data, compositions and methods for detecting genetic polymorphisms, methods for evaluating drugs using genetic polymorphisms and screening methods for drugs.
摘要:
An agent for curing ischemic myocardial disease which contains an effective amount of diadenosine 5',5'"-p.sup.1,p.sup.4 -tetraphosphate (Ap4A) of formula (I): ##STR1## or a pharmaceutically-acceptable salt thereof.
摘要:
A deliberated hypotensive agent is composed of diadenosine 5', 5'"-p.sup.1,p.sup.4 -tetraphosphate with formula (I) or a salt thereof for which administration is medically permissible in an effective amount: ##STR1##
摘要:
A data synchronization method is disclosed by which a data synchronization process is performed automatically between a plurality of information apparatus. A record which forms data possessed by each information apparatus includes a data item representative of deletion information of the record and another data item. Time stamp information is fetched for each of the data items. A first one of the information apparatus transmits self data thereof including the time stamp information to a second one of the information apparatus which is a destination of data synchronization. Upon reception of the data transmitted from the first information apparatus, the second information apparatus compares the time stamp information for each of the data items included in the record of an updating object between the received data and the self data thereof and fetches the newest data to update the self data thereof.
摘要:
In a remote conference system based on a client server model, each of conference terminals comprises a terminal packet memory for storing a voice data of the conference terminal. When a synthesized voice data is multicasted to the conference terminals, each of the conference terminals searches own voice data included in the synthesized voice data from the terminal packet memory. An echo canceler in each of the conference terminals cancels own voice data from the synthesized voice data, thereby performing an echo canceling processing.